Oxidative stress in Alzheimer's disease hippocampus: a topographical study
- PMID: 20863531
- DOI: 10.1016/j.jns.2010.08.029
Oxidative stress in Alzheimer's disease hippocampus: a topographical study
Abstract
Advanced glycation end-products (AGEs) and their receptor (RAGE) are molecules related to oxidative stress demonstrated in aging and in several pathological disorders including Alzheimer's disease (AD). Aging has been considered the main risk factor for AD. Amyloid deposits (Aβ-D) and neurofibrillary tangles (NFT) are pathological changes related to AD involving hippocampal regions. Different degrees of AD pathology have been described according to distribution of NFTs in different topographical regions of hippocampus and cerebral cortex. The hippocampus shows a selective vulnerability under several noxes especially those including hypoxia. Hypoxia in the nervous tissue induces oxidative stress. In an attempt to find out more about anatomical distribution of the oxidative stress through hippocampal regions in AD, a collection of brains were studied. Samples from deceased patients who had suffered from AD and from age-matched controls were immunohistochemically studied with AGE and RAGE antibodies according to a topographical division of the hippocampus and brain cortical regions. Results suggest that an oxidative stress pathway starts in the CA3 sector progresses to CA1 and then continues to other hippocampal and cortical areas building a pathoclitic pathway for Alzheimer's disease progression.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.Free Radic Biol Med. 2004 May 15;36(10):1241-7. doi: 10.1016/j.freeradbiomed.2004.02.006. Free Radic Biol Med. 2004. PMID: 15110389
-
Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.Acta Neuropathol. 2002 Aug;104(2):113-22. doi: 10.1007/s00401-002-0523-y. Epub 2002 Jun 4. Acta Neuropathol. 2002. PMID: 12111353
-
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22. Neurobiol Aging. 2011. PMID: 19464758 Review.
-
Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.Exp Neurol. 1994 Jul;128(1):13-26. doi: 10.1006/exnr.1994.1108. Exp Neurol. 1994. PMID: 8070517
-
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.Curr Pharm Des. 2008;14(10):973-8. doi: 10.2174/138161208784139693. Curr Pharm Des. 2008. PMID: 18473848 Review.
Cited by
-
Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder.Neurochem Res. 2012 Aug;37(8):1761-7. doi: 10.1007/s11064-012-0788-z. Epub 2012 May 5. Neurochem Res. 2012. PMID: 22562440
-
Effect of a Strawberry and Spinach Dietary Supplement on Spatial Learning in Early and Late Middle-Aged Female Rats.Antioxidants (Basel). 2018 Dec 20;8(1):1. doi: 10.3390/antiox8010001. Antioxidants (Basel). 2018. PMID: 30577447 Free PMC article.
-
Selective Vulnerability of Hippocampi for Nitric Oxide Synthases in Alzheimer's Disease Pathology and Cognitive Abilities.Neurochem Res. 2025 Jun 12;50(3):197. doi: 10.1007/s11064-025-04444-5. Neurochem Res. 2025. PMID: 40504299
-
Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment.Brain Pathol. 2024 Jan;34(1):e13202. doi: 10.1111/bpa.13202. Epub 2023 Aug 24. Brain Pathol. 2024. PMID: 37619589 Free PMC article.
-
Age-related neurodegeneration and memory loss in down syndrome.Curr Gerontol Geriatr Res. 2012;2012:463909. doi: 10.1155/2012/463909. Epub 2012 Mar 20. Curr Gerontol Geriatr Res. 2012. PMID: 22545043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous